MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines

Biochemical and Biophysical Research Communications

Volumn 373, Issue 4, 2008, Pages 607-612

  Crawford, M ^a   Brawner, E ^a   Batte, K ^a   Yu, L ^b   Hunter, M G ^a   Otterson, G A ^a   Nuovo, G ^a   Marsh, C B ^a   Nana Sinkam, S P ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Adhesion; Crk; Invasion; Lung cancer; MicroRNA

Indexed keywords

CRK LIKE PROTEIN; MESSENGER RNA; MICRORNA; PROTEIN MIR 126;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA DEGRADATION; RNA TRANSLATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-CRK; RNA, MESSENGER;

EID: 48949115082     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.090     Document Type: Article

References (31)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
2. Feller S.M. Crk family adaptors-signalling complex formation and biological roles 2. Oncogene 20 (2001) 6348-6371
3. Kobashigawa Y., Sakai M., Naito M., Yokochi M., Kumeta H., Makino Y., Ogura K., Tanaka S., and Inagaki F. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK 2. Nat. Struct. Mol. Biol. 14 (2007) 503-510
4. Rodrigues S.P., Fathers K.E., Chan G., Zuo D., Halwani F., Meterissian S., and Park M. CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Mol. Cancer Res. 3 (2005) 183-194
5. Miller C.T., Chen G., Gharib T.G., Wang H., Thomas D.G., Misek D.E., Giordano T.J., Yee J., Orringer M.B., Hanash S.M., and Beer D.G. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas 1. Oncogene 22 (2003) 7950-7957
6. Nishihara H., Tanaka S., Tsuda M., Oikawa S., Maeda M., Shimizu M., Shinomiya H., Tanigami A., Sawa H., and Nagashima K. Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett. 180 (2002) 55-61
7. Lamorte L., Rodrigues S., Sangwan V., Turner C.E., and Park M. Crk associates with a multimolecular Paxillin/GIT2/beta-PIX complex and promotes Rac-dependent relocalization of Paxillin to focal contacts. Mol. Biol. Cell 14 (2003) 2818-2831
8. Hirata T., Nagai H., Koizumi K., Okino K., Harada A., Onda M., Nagahata T., Mikami I., Hirai K., Haraguchi S., Jin E., Kawanami O., Shimizu K., and Emi M. Amplification, up-regulation and over-expression of C3G (CRK SH3 domain-binding guanine nucleotide-releasing factor) in non-small cell lung cancers. J. Hum. Genet. 49 (2004) 290-295
9. Wang L., Tabu K., Kimura T., Tsuda M., Linghu H., Tanino M., Kaneko S., Nishihara H., and Tanaka S. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4 1. Biochem. Biophys. Res. Commun. 362 (2007) 976-981
10. Linghu H., Tsuda M., Makino Y., Sakai M., Watanabe T., Ichihara S., Sawa H., Nagashima K., Mochizuki N., and Tanaka S. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 25 (2006) 3547-3556
11. Di Leva G., Calin G.A., and Croce C.M. MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res. C Embryo Today 78 (2006) 180-189
12. Krutzfeldt J., and Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 4 (2006) 9-12
13. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., Shimizu M., Cimmino A., Zupo S., Dono M., Dell′Aquila M.L., Alder H., Rassenti L., Kipps T.J., Bullrich F., Negrini M., and Croce C.M. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA 101 (2004) 11755-11760
14. Jiang J., Lee E.J., Gusev Y., and Schmittgen T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 33 (2005) 5394-5403
15. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., Yuen S.T., Chan T.L., Kwong D.L., Au G.K., Liu C.G., Calin G.A., Croce C.M., and Harris C.C. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299 (2008) 425-436
16. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., Croce C.M., and Harris C.C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
17. Calin G.A., and Croce C.M. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J. Clin. Invest. 117 (2007) 2059-2066
18. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Menard S., Palazzo J.P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., and Croce C.M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005) 7065-7070
19. Kumar M.S., Erkeland S.J., Pester R.E., Chen C.Y., Ebert M.S., Sharp P.A., and Jacks T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. USA 105 (2008) 3903-3908
20. Kumar M.S., Lu J., Mercer K.L., Golub T.R., and Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat.Genet. 39 (2007) 673-677
21. Yu S.L., Chen H.Y., Chang G.C., Chen C.Y., Chen H.W., Singh S., Cheng C.L., Yu C.J., Lee Y.C., Chen H.S., Su T.J., Chiang C.C., Li H.N., Hong Q.S., Su H.Y., Chen C.C., Chen W.J., Liu C.C., Chan W.K., Chen W.J., Li K.C., Chen J.J., and Yang P.C. MicroRNA signature predicts survival and relapse in lung cancer 4. Cancer Cell 13 (2008) 48-57
22. Schmidt M., De M.A., Smyczek T., Gray A., Parker L., Filvaroff E., French D., van D.S., Klumperman J., and Ye W. The role of Egfl7 in vascular morphogenesis. Novartis Found. Symp. 283 (2007) 18-28
23. Schmidt M., Paes K., De M.A., Smyczek T., Yang S., Gray A., French D., Kasman I., Klumperman J., Rice D.S., and Ye W. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 134 (2007) 2913-2923
24. Fitch M.J., Campagnolo L., Kuhnert F., and Stuhlmann H. Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev. Dyn. 230 (2004) 316-324
25. Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., and Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA 105 (2008) 1516-1521
26. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., and Jones P.A. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9 (2006) 435-443
27. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., and Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (2008) 147-152
28. Martin M.M., Buckenberger J.A., Jiang J., Malana G.E., Nuovo G.J., Chotani M., Feldman D.S., Schmittgen T.D., and Elton T.S. The human angiotensin II Type 1 receptor +1166 A/C polymorphism attenuates MicroRNA-155 binding. J. Biol. Chem. 282 (2007) 24262-24269
29. Matsubara H., Takeuchi T., Nishikawa E., Yanagisawa K., Hayashita Y., Ebi H., Yamada H., Suzuki M., Nagino M., Nimura Y., Osada H., and Takahashi T. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26 (2007) 6099-6105
30. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G., Louis D.N., Christiani D.C., Settleman J., and Haber D.A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350 (2004) 2129-2139
31. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838